Gaia AG trials digital health app Liebria for primary hypertension
A clinical trial is underway to evaluate the effectiveness of the Liebria digital health application in managing primary hypertension.
Company
Pharmaceutical intelligence for digital therapeutics market with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.